Trial Profile
Retrospective study exploring efficacy of nivolumab for patients with recurrent high grade gliomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2018
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary) ; Bevacizumab
- Indications Glioma
- Focus Therapeutic Use
- 18 Dec 2018 New trial record